When patent protection on drugs ends, however, companies face generic competition, as competitors such as Teva make copies of ...

Wondering if Teva Pharmaceutical Industries is now a bargain or if you might be late to the party? You're not alone. Investors are searching for value in a market where expectations are shifting fast.

Teva Pharmaceutical Industries stock has drawn renewed attention after consensus analyst price targets edged higher, rising from $27.45 to $27.90 per share. This subtle adjustment reflects a blend of ...

Eli Lilly, the pharmaceutical company founded nearly 150 years ago by a Civil War veteran of the same name, on Friday briefly became the first drugmaker to reach $1 trillion in market value. The ...

Teva Pharmaceuticals Inc. ’s claims against a Biden-era drug price negotiation program either fail on the merits or are unripe, a federal judge ruled Thursday. Judge Sparkle L. Sooknanan ruled the ...

Teva Pharmaceutical Industries is launching its first global innovation platform, challenging startups to submit novel strategies to tackle seven pervasive industry hurdles that run the gamut from ...